ICM
Invenomic Capital Management Portfolio holdings
AUM
$1.91B
1-Year Est. Return
5.33%
1 Year Est. Return
-5.33%
AUM
$1.91B
AUM Growth
+$150M
(+8.5%)
Holding
186
Top Buys
| 1 | +$24.8M | |
| 2 | +$23.5M | |
| 3 | +$22.9M | |
| 4 |
DoubleVerify
DV
|
+$21.7M |
| 5 |
CONMED
CNMD
|
+$19.8M |
Top Sells
| 1 | +$29.6M | |
| 2 | +$29.3M | |
| 3 | +$21.9M | |
| 4 |
NGD
New Gold Inc
NGD
|
+$20.9M |
| 5 |
VRNT
Verint Systems
VRNT
|
+$19.6M |
Sector Composition
| 1 | Technology | 21.66% |
| 2 | Healthcare | 19.93% |
| 3 | Consumer Discretionary | 16.36% |
| 4 | Materials | 11% |
| 5 | Industrials | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Qualcomm
QCOM
$183B
| – | – |
-13,557
|
|
||
177
Regal Rexnord
RRX
$9.61B
| – | – |
-72,133
|
|
||
178
Rayonier
RYN
$3.32B
| – | – |
-446,135
|
|
||
179
SPDR S&P 500 ETF Trust
SPY
$699B
| – | – |
0
|
|
||
180
10x Genomics
TXG
$2.28B
| – | – |
-236,064
|
|
||
181
Unity
U
$19.4B
| – | – |
-489,191
|
|
||
182
Visteon
VC
$2.76B
| – | – |
-62,941
|
|
||
183
WEX
WEX
$5.1B
| – | – |
-50,683
|
|
||
184
Xperi
XPER
$270M
| – | – |
-247,955
|
|
||
185
Zimmer Biomet
ZBH
$18.7B
| – | – |
-89,088
|
|
||
186
Metallus
MTUS
$702M
| – | – |
-697,815
|
|